Skip to main content

Animations

MJFF Publications

5221 - 5230 of 8684 Results
Title
Year
  • Year
  • 2024
  • 2025
  • 2024
  • 2021
  • 2024
  • 2022
  • 2020
  • 2025
  • 2022
  • 2021
  • Summary Details
    RESTRICTED
    Title: Diffusion tensor metrics, motor and non-motor symptoms in de novo Parkinson’s disease
    Journal Name: Neuroradiology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00234-024-03452-6
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Two-phase hybrid explainable machine learning model in the early diagnosis of motor and non-motor symptoms of Parkinson’s disease
    Journal Name: Neurocomputing
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neucom.2025.130004
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Randomized controlled trial of intermittent hypoxia in Parkinson’s disease: study rationale and protocol
    Journal Name: BMC Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12883-024-03702-3
    Citation Count: 5
  • Summary Details
    OPEN
    Title: TNF-α and α-synuclein fibrils differently regulate human astrocyte immune reactivity and impair mitochondrial respiration
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.celrep.2021.108895
    Citation Count: 49
  • Summary Details
    OPEN
    Title: RTN2 deficiency results in an autosomal recessive distal motor neuropathy with lower limb spasticity
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awae091
    Citation Count: 4
  • Summary Details
    OPEN
    Title: The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein models
    Journal Name: Disease Models & Mechanisms
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1242/dmm.049192
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Analysis of Heterozygous PRKN Variants and Copy‐Number Variations in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28299
    Citation Count: 45
  • Summary Details
    OPEN
    Title: Interactions of Oligodendrocyte Precursor Cells and Dopaminergic Neurons in the Mouse Substantia Nigra
    Journal Name: Journal of Neurochemistry
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/jnc.16298
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Design of the PERSPECTIVE study: PERsonalized SPEeCh Therapy for actIVE conversation in Parkinson’s disease (randomized controlled trial)
    Journal Name: Trials
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13063-022-06160-9
    Citation Count: 7
  • Summary Details
    OPEN
    Title: T-cell based immunotherapies for Parkinson’s disease
    Journal Name: Exploration of Neuroprotective Therapy
    Publisher: Open Exploration Publishing
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.37349/ent.2021.00007
    Citation Count: 11
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.